Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP5

TARGETED GENE VECTOR Résumé de rapport

Project ID: QLK3-CT-1999-00364
Financé au titre de: FP5-LIFE QUALITY
Pays: France

Validation of a Tetracycline conditional expression retroviral vector expressing efficiently and safely a therapeutic gene in liver tumours in murine models

A tetracycline conditional expression retroviral vector, which has been validated in vitro, is currently being validated for its efficient and safe transduction of a therapeutic gene in liver tumours in murine and rat models. The vector system is being tested for appropriate propagation and transgene expression within the tumour as well as for any detectable dissemination outside of the tumour. It is also being tested for its therapeutic efficacy, alone or in combination with retroviral vectors transducing other genes of interest.

Contact

David KLATZMANN, (Professor)
Tél.: +33-142177461
Fax: +33-142177462
E-mail